Clinical Trial Update: Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing telbivudine in combination with adefovir versus continued adefovir monotherapy for chronic hepatitis B has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Hepatitis B | Phase 4 | Status: WITHDRAWN